• June 12, 2007

Stephen A. Ross joins Cytogen Corp. in the newly created position of SVP/sales and marketing.

Ross arrives at the oncology product specialty pharmaceutical company on July 9 from GlaxoSmithKline, where he has served in various marketing positions for 15 years.

Princeton, N.J.-based Cytogen markets three therapeutic products and one diagnostic product to the U.S. oncology market. The Company is also developing CYT-500, a third-generation radio labeled antibody to treat prostate cancer.

--Tanya Irwin